Cellbricks Therapeutics | RoundOS

Weekly digest by email

Loading companies…

Cellbricks Therapeutics | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Mar 25, 2026	Seed+Non-Dilutive	€10M	Atlantic Labs — Role not disclosedb2venture — Role not disclosedBrandenburg Kapital — Role not disclosedHigh-Tech Gründerfonds — Role not disclosedLifeX Ventures — Role not disclosed

Investors

Atlantic LabsSeed+Non-Dilutive b2ventureSeed+Non-Dilutive Brandenburg KapitalSeed+Non-Dilutive High-Tech GründerfondsSeed+Non-Dilutive LifeX VenturesSeed+Non-Dilutive

Coverage

Mar 25, 2026Cellbricks Therapeutics · Seed+Non-Dilutive

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

cellbricks-therapeutics.com ↗